about
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)Management of children and young people (CYP) with asthma: a clinical audit report.A review of asthma care in 50 general practices in Bedfordshire, United KingdomIf it's 'only' asthma, why are children still dying?Asthma reviews in children: what have we learned?Understanding Dry Powder Inhalers: Key Technical and Patient Preference AttributesGINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents
P50
Q26751471-176E7382-3859-46A8-9BFA-D1178D9C82B7Q55097415-BF3BF15B-C062-43AE-B6F7-A98D307DE1A5Q90524708-BB6739C4-59CF-4729-B149-E489E5DDFDC4Q92216529-373733B2-0B03-47CD-B8FE-55AF86FD6348Q92380477-3E20DF17-A9D4-481C-A492-CB05F3FED70BQ93066145-C7D29D2A-DF8A-482F-908C-30638ECA15B6Q93087030-142DD98E-3607-4B1B-BC09-07A76391B742
P50
description
researcher
@en
name
Mark L Levy
@en
type
label
Mark L Levy
@en
prefLabel
Mark L Levy
@en
P31
P496
0000-0002-1807-3246